Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Cassava Sciences and Ocugen Stock Fell With the Nasdaq


The stock market got choppy on Wednesday morning, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) wasn't able to sustain its recent push higher to all-time records. As of 11:15 a.m. EST, the Nasdaq was down about 0.5%, having given up an early gain.

Big-name companies have helped power the Nasdaq higher, yet investors have also benefited from some smaller companies that have a lot more long-term growth potential. On Wednesday, two of the most popular stocks on the Nasdaq recently -- Cassava Sciences (NASDAQ: SAVA) and Ocugen (NASDAQ: OCGN) -- posted sharp losses that showed that biotech stocks could remain volatile for quite some time despite their favorable prospects.

Shares of Cassava Sciences were down 15% Wednesday morning. Investors weren't happy about the terms that the biotech company settled for in raising capital.

Continue reading


Source Fool.com

Like: 0
Share

Comments